GenusPlus Group Ltd.

As of June 30, 2026, GenusPlus Group Ltd. carries a market capitalization of 2.23B, placing it among publicly traded companies globally. Its enterprise value stands at 1.85B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

GenusPlus Group Ltd.'s next confirmed earnings release is scheduled for February 25, 2027.

As of June 30, 2026, GenusPlus Group Ltd. has 203.15M shares outstanding.

As of June 30, 2026, GenusPlus Group Ltd. trades at a trailing price-to-earnings ratio of 41.01. The price-to-sales ratio is 1.57, and the price-to-book ratio stands at 5.60.

As of June 30, 2026, GenusPlus Group Ltd. trades at an EV/EBITDA multiple of 19.57 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 1.44 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 25.56 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. These enterprise value multiples are built on an enterprise value of 1.85B versus a market cap of 2.23B, with the gap driven by net debt and cash on the balance sheet.

As of June 30, 2026, GenusPlus Group Ltd. maintains a current ratio of 1.54, meaning it holds 1.5x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 24.16, indicating elevated leverage, while an interest coverage ratio of 21.37 demonstrates strong ability to service its debt obligations.

Over the twelve months ended June 30, 2026, GenusPlus Group Ltd. posted a return on equity (ROE) of 17.57, showing how much profit the company earns on every dollar of shareholder capital. Return on invested capital (ROIC) comes in at 13.70 - the clearest signal of whether the business earns more on its capital than that capital costs, and the core measure of a durable competitive advantage. Return on assets (ROA) stands at 6.95, measuring how efficiently the asset base is converted into earnings. Return on capital employed (ROCE) is 14.74, useful for judging operating efficiency across full business cycles. The company generates approximately 511,814.87 in revenue per employee across its workforce of 2,503.00, a quick read on workforce productivity versus industry peers. Inventory turnover of 89.67 indicates how many times GenusPlus Group Ltd. sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended June 30, 2026, GenusPlus Group Ltd. recorded 23.60M in income tax expense. That works out to an effective tax rate of 32.50, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 72.63M, leaving 49.02M in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

As of the close on October 22, 2026, GenusPlus Group Ltd.'s stock has gained approximately 30.41% over the past 52 weeks. The 50-day moving average sits at 8.91, while the 200-day moving average is 8.69.

Over the twelve months ended June 30, 2026, GenusPlus Group Ltd. generated 1.28B in revenue and converted that into 49.02M in net income, yielding earnings per share of 0.26. EBITDA reached 94.48M, while operating income came in at 72.29M.

As of June 30, 2026, GenusPlus Group Ltd. holds 476.05M in cash and equivalents against 96.20M in total debt, resulting in a net debt position of -444.25M. Total book value stands at 398.11M, with working capital of 243.83M providing operational flexibility.

These figures cover the twelve months ended June 30, 2026.

Over the twelve months ended June 30, 2026, GenusPlus Group Ltd. posted a gross margin of 72.32, reflecting its pricing power and cost economics. The operating margin of 5.64 and net profit margin of 3.83 provide insight into operational efficiency.

Over the twelve months ended June 30, 2026, GenusPlus Group Ltd. paid dividends of 0.06 per share. The dividend payout ratio of 20.70 indicates the proportion of earnings distributed to shareholders, a key gauge of how sustainable the dividend is and how much room remains for future dividend growth. Total shareholder yield is negative at -8.21, meaning GenusPlus Group Ltd. raised more capital through share issuance and new debt than it returned via dividends and buybacks.

As of June 30, 2026, GenusPlus Group Ltd. has an Altman Z-Score of 4.89, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.